Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRRT with radiolabeled somatostatin analogs in somatostatin receptor-positive tumors
2016-005129-35Phase 2Terminated
- Sponsor
- Azienda Ospedaliero-Universitaria di Ferrara
- Start
- Jun 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of edotreotide in apudoma (NET), neuroendocrine tumor (NET), sponsored by Azienda Ospedaliero-Universitaria di Ferrara. Started Jun 2021; status: terminated.
02
Drugs
edotreotide
03
Conditions
apudoma (NET)neuroendocrine tumor (NET)
Beyond the preview
Go deeper on 2016-005129-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005129-35.